Singapore’s Health Sciences Authority (HSA) has announced a retail-level recall of one batch of Famodine Tablet 20mg, a therapeutic product containing famotidine, following a quality monitoring finding.

• Batch Details: Batch No. 232218 (Registration No. SIN09129P), supplied by Duopharma (Singapore) Pte Ltd.
• Reason: Out-of-specification test result for assay identified during quality monitoring.
• Classification: Classified as a Class 2 recall, indicating it is unlikely to cause serious adverse health outcomes.

This summary is based on an announcement issued by the Health Sciences Authority.

Image for illustrative purposes only. Source: Canva.